Last $88.91 USD
Change Today -3.10 / -3.37%
Volume 2.5M
VRTX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ian F. Smith CPA, ACA

Chief Financial Officer and Executive Vice President, Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 53 board members in 4 different organizations across 5 different industries.

See Board Relationships
48$4,184,762
As of Fiscal Year 2013

Background*

Mr. Ian F. Smith, CPA, ACA, has been the Chief Financial Officer of Vertex Pharmaceuticals Inc., since October 2001 and has been its Executive Vice President since February 2006. Mr. Smith serves as a Member of the Executive Team of Vertex Pharmaceuticals Inc. and holds responsibility for a wide variety of core functions, including Finance, Strategic Communications, Information Systems, Operations and Human Resources. He served as a Senior Vice President of Vertex Pharmaceuticals ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

2004-Present
Director and Member of Audit Committee
2005-N/A
Former Director and Chairman of Audit Committee
2005-N/A
Former Director and Chairman of the Finance Committee
2006-Present
Independent Director and Chairman of Audit Committee
2007-Present
Director, Member of Audit Committee and Member of Nominations & Governance Committee
2008-Present
Director and Chairman of Audit Committee

Education*

BA
Manchester Metropolitan University

Other Affiliations*

Annual Compensation*

Salary$582,959
Total Annual Compensation$582,959

Stock Options*

Restricted Stock Awards$544,988
All Other Compensation$12,675
Exercised Options739,643
Exercised Options Value$34,925,940
Exercisable Options65,567
Exercisable Options Value$2,058,677
Unexercisable Options174,610
Unexercisable Options Value$4,396,968
Total Value of Options$41,381,584
Total Number of Options979,820

Total Compensation*

Total Annual Cash Compensation$1,278,134
Total Short Term Compensation$582,959
Other Long Term Compensation$557,663
Total Calculated Compensation$4,184,762
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $88.91 USD -3.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Leonard Bell M.D.Co-Founder, Chief Executive Officer, Treasurer and Director
Alexion Pharmaceuticals, Inc.
$1.2M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.